×
DexCom Inventory 2010-2024 | DXCM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DexCom inventory for the quarter ending September 30, 2024 was
$0.586B
, a
17.59% increase
year-over-year.
DexCom inventory for 2023 was
$0.56B
, a
82.46% increase
from 2022.
DexCom inventory for 2022 was
$0.307B
, a
14.16% decline
from 2021.
DexCom inventory for 2021 was
$0.357B
, a
52.24% increase
from 2020.
View More
DexCom Inventory 2010-2024 | DXCM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DexCom inventory for 2023 was
$0.56B
, a
82.46% increase
from 2022.
DexCom inventory for 2022 was
$0.307B
, a
14.16% decline
from 2021.
DexCom inventory for 2021 was
$0.357B
, a
52.24% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$212.6B
Intuitive Surgical (ISRG)
$186.7B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.5B
Edwards Lifesciences (EW)
$38.8B
IDEXX Laboratories (IDXX)
$35.5B
Waters (WAT)
$22.9B
SONOVA HOLDING (SONVY)
$22B
STERIS (STE)
$21.3B
Hologic (HOLX)
$18.4B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Sysmex ADR (SSMXY)
$12.4B
Globus Medical (GMED)
$11.1B
Teleflex (TFX)
$9.2B
Penumbra (PEN)
$8.9B
Masimo (MASI)
$8.6B
Glaukos (GKOS)
$7.7B
PROCEPT BioRobotics (PRCT)
$5B
Integer Holdings (ITGR)
$4.5B
Inari Medical (NARI)
$3B
TransMedics (TMDX)
$2.9B
Veracyte (VCYT)
$2.9B
LivaNova (LIVN)
$2.8B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.2B
Integra LifeSciences Holdings (IART)
$2B
RxSight (RXST)
$1.9B
Alphatec Holdings (ATEC)
$1.3B
Artivion (AORT)
$1.2B